TA-HPV immunotherapeutic vaccine: Began Phase II trial

Cantab Pharmaceuticals plc (CNTBY), Cambridge, U.K. Product: TA-HPV immunotherapeutic vaccine Indication: Advanced cervical cancer Status: Began Phase II trial ...